|
HY-Y0032-5g
|
MedChemexpress LLC
|
Thiosemicarbazide [CAS 79-19-6]
|
|
|
|
|
HY-Y0032-1mL
|
MedChemexpress LLC
|
Thiosemicarbazide [CAS 79-19-6] (10mM in DMSO)
|
|
|
|
|
HY-128914-1mg
|
MedChemexpress LLC
|
Tubulysin [CAS 1943604-24-7]
|
|
Cancer-programmed cell death
|
|
|
HY-128914-5mg
|
MedChemexpress LLC
|
Tubulysin [CAS 1943604-24-7]
|
|
Cancer-programmed cell death
|
|
|
HY-17518A-10mg
|
MedChemexpress LLC
|
(S,S)-Valifenalate [CAS 283159-94-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-17518A-25mg
|
MedChemexpress LLC
|
(S,S)-Valifenalate [CAS 283159-94-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-17518A-5mg
|
MedChemexpress LLC
|
(S,S)-Valifenalate [CAS 283159-94-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-17518A-50mg
|
MedChemexpress LLC
|
(S,S)-Valifenalate [CAS 283159-94-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-17518A-1mL
|
MedChemexpress LLC
|
(S,S)-Valifenalate [CAS 283159-94-4] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-B1117-250mg
|
MedChemexpress LLC
|
Cefoxitin (sodium) [CAS 33564-30-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1117-1mL
|
MedChemexpress LLC
|
Cefoxitin (sodium) [CAS 33564-30-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-W009970-5g
|
MedChemexpress LLC
|
Ethyl 2-(benzylamino)acetate [CAS 6436-90-4]
|
|
|
|
|
HY-16200-10mg
|
MedChemexpress LLC
|
Ethynylcytidine [CAS 180300-43-0]
|
|
Cancer-programmed cell death
|
|
|
HY-16200-25mg
|
MedChemexpress LLC
|
Ethynylcytidine [CAS 180300-43-0]
|
|
Cancer-programmed cell death
|
|
|
HY-16200-5mg
|
MedChemexpress LLC
|
Ethynylcytidine [CAS 180300-43-0]
|
|
Cancer-programmed cell death
|
|
|
HY-16200-1mL
|
MedChemexpress LLC
|
Ethynylcytidine [CAS 180300-43-0] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-B1075-100mg
|
MedChemexpress LLC
|
Fosfomycin (calcium) [CAS 26016-98-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-B1075-1mL
|
MedChemexpress LLC
|
Fosfomycin (calcium) [CAS 26016-98-8] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-W016420-500mg
|
MedChemexpress LLC
|
Fosfomycin (sodium) [CAS 26016-99-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-W016420-1mL
|
MedChemexpress LLC
|
Fosfomycin (sodium) [CAS 26016-99-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-B0609-10mg
|
MedChemexpress LLC
|
Fosfomycin (tromethamine) [CAS 78964-85-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0609-100mg
|
MedChemexpress LLC
|
Fosfomycin (tromethamine) [CAS 78964-85-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0609-5mg
|
MedChemexpress LLC
|
Fosfomycin (tromethamine) [CAS 78964-85-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0609-50mg
|
MedChemexpress LLC
|
Fosfomycin (tromethamine) [CAS 78964-85-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-75920-100mg
|
MedChemexpress LLC
|
Inhoffen Lythgoe diol [CAS 64190-52-9]
|
|
|
|
